FUJIFILM Pharmaceuticals U.S.A., Inc.

Exhibitor

FUJIFILM Corporation has been developing licensable ionizable lipids for LNP formulations. The most advanced one is FL-0445 used in Phase 3 studies of COVID vaccines. We also developed a safer liver-targeting lipid and some candidates for liver de-targeting. 

A one-stop CDMO service from mRNA/LNP manufacturing to fill finish for early stage development through commercial products is available.

website